Citigroup’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103M Buy
434,181
+93,846
+28% +$19.5M 0.03% 469
2026
Q1
$71.9M Sell
340,335
-55,503
-14% -$12M 0.03% 516
2025
Q4
$81.3M Sell
395,838
-5,916
-1% -$1.11M 0.04% 436
2025
Q3
$63.1M Buy
401,754
+4,962
+1% +$766K 0.03% 547
2025
Q2
$66.7M Buy
396,792
+5,814
+1% +$863K 0.03% 491
2025
Q1
$53.9M Sell
390,978
-208,450
-35% -$26.6M 0.03% 533
2024
Q4
$70.9M Buy
599,428
+194,552
+48% +$22.7M 0.04% 383
2024
Q3
$44.7M Buy
404,876
+71,328
+21% +$7.46M 0.03% 582
2024
Q2
$32.8M Sell
333,548
-62,964
-16% -$6.42M 0.02% 680
2024
Q1
$44.4M Buy
396,512
+157,340
+66% +$17M 0.03% 541
2023
Q4
$24.1M Sell
239,172
-184,708
-44% -$18.3M 0.02% 762
2023
Q3
$36.8M Buy
423,880
+81,175
+24% +$7.34M 0.03% 537
2023
Q2
$32.4M Buy
342,705
+10,050
+3% +$849K 0.02% 609
2023
Q1
$25.1M Sell
332,655
-49,462
-13% -$3.73M 0.02% 722
2022
Q4
$29.4M Buy
382,117
+25,977
+7% +$1.97M 0.02% 611
2022
Q3
$23.7M Sell
356,140
-15,010
-4% -$951K 0.02% 700
2022
Q2
$19.4M Buy
371,150
+77,880
+27% +$4.43M 0.01% 811
2022
Q1
$16.6M Sell
293,270
-281,650
-49% -$15.1M 0.01% 1029
2021
Q4
$29.6M Buy
574,920
+198,472
+53% +$9.73M 0.02% 809
2021
Q3
$18.6M Buy
376,448
+2,598
+0.7% +$141K 0.01% 1048
2021
Q2
$21.3M Buy
373,850
+27,696
+8% +$1.62M 0.01% 959
2021
Q1
$21M Sell
346,154
-13,888
-4% -$767K 0.01% 924
2020
Q4
$19.3M Buy
360,042
+51,380
+17% +$2.67M 0.01% 1060
2020
Q3
$14.5M Buy
308,662
+37,051
+14% +$1.9M 0.01% 1109
2020
Q2
$14.2M Buy
271,611
+77,087
+40% +$3.97M 0.01% 1066
2020
Q1
$9.33M Sell
194,524
-45,300
-19% -$2.35M 0.01% 1209
2019
Q4
$12.1M Sell
239,824
-85,324
-26% -$4.41M 0.01% 1325
2019
Q3
$15.3M Sell
325,148
-13,081
-4% -$597K 0.01% 1093
2019
Q2
$15.9M Buy
338,229
+169,740
+101% +$7.83M 0.01% 1071
2019
Q1
$8.11M Sell
168,489
-105,808
-39% -$5.3M 0.01% 1413
2018
Q4
$12.2M Buy
274,297
+67,752
+33% +$3.53M 0.01% 1126
2018
Q3
$11.2M Buy
206,545
+123,146
+148% +$6.3M 0.01% 1212
2018
Q2
$4.07M Sell
83,399
-13,011
-13% -$738K ﹤0.01% 2025
2018
Q1
$6.04M Sell
96,410
-189,573
-66% -$13M 0.01% 1609
2017
Q4
$17.5M Buy
285,983
+21,161
+8% +$1.31M 0.01% 921
2017
Q3
$17.7M Buy
264,822
+41,692
+19% +$2.95M 0.01% 859
2017
Q2
$17.4M Buy
223,130
+36,428
+20% +$2.75M 0.02% 828
2017
Q1
$15.2M Buy
186,702
+55,432
+42% +$4.36M 0.01% 875
2016
Q4
$9.45M Buy
131,270
+92,660
+240% +$6.7M 0.01% 1239
2016
Q3
$3M Sell
38,610
-2,844
-7% -$230K ﹤0.01% 2139
2016
Q2
$3.23M Sell
41,454
-76,255
-65% -$6.08M ﹤0.01% 1958
2016
Q1
$9.64M Sell
117,709
-147,658
-56% -$12M 0.01% 1040
2015
Q4
$23.7M Buy
265,367
+81,120
+44% +$6.89M 0.02% 668
2015
Q3
$14.2M Sell
184,247
-82,524
-31% -$6.9M 0.01% 905
2015
Q2
$22.3M Buy
266,771
+19,825
+8% +$1.75M 0.02% 726
2015
Q1
$22.3M Buy
246,946
+59,561
+32% +$5.13M 0.02% 714
2014
Q4
$15.1M Sell
187,385
-31,371
-14% -$2.48M 0.01% 970
2014
Q3
$16.4M Sell
218,756
-156,162
-42% -$11.4M 0.01% 927
2014
Q2
$25.7M Buy
374,918
+37,123
+11% +$2.53M 0.02% 643
2014
Q1
$23.6M Sell
337,795
-62,429
-16% -$4.34M 0.02% 624
2013
Q4
$26.7M Sell
400,224
-50,374
-11% -$3.08M 0.02% 624
2013
Q3
$23.5M Sell
450,598
-71,547
-14% -$3.63M 0.02% 658
2013
Q2
$24.6M Buy
+522,145
New +$23.8M 0.02% 592

Other funds holding CAH

Citigroup's CAH Position: Q2 2026 in Review

Citigroup increased its Cardinal Health (CAH) stake by 28% in Q2 2026, buying an estimated $19.5M and bringing the position to 434,181 shares worth $103M. The position accounts for 0.03% of the portfolio, ranked #469.

Citigroup first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Citigroup held 434,181 shares of Cardinal Health worth $103M as of Q2 2026.
  • Citigroup bought 93,846 Cardinal Health shares in Q2 2026, an estimated $19.5M.
  • Cardinal Health made up 0.03% of Citigroup's portfolio in Q2 2026, its #469 holding.
  • Citigroup first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.